Limited activity: This researcher has not published recently (last publication: 1993). Profile data may be outdated.
Match tier Likely match
Presence Current · Arkansas
Last published 1993
Sources OpenAlex · ORCID
Refreshed 2026-10-03

Raeann Townsend

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Role not yet determined Is this you? Add your title

Also affiliated: Oregon Health & Science University (1988–1993); University of Michigan (1993); Michigan Medicine (1993); University of Kansas Medical Center (1988); SWOG Cancer Research Network (1988)

3 h-index 3 pubs 115 cited

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols
  • Brain Neoplasms
  • Cisplatin
  • Dacarbazine
  • Female
  • Humans
  • Male
  • Melanoma
  • Middle Aged
  • Neoplasm Staging
  • Survival Analysis

Biography and Research Information

OverviewAI-generated summary

Raeann Townsend's research has focused on evaluating the efficacy of specific chemotherapeutic agents in treating advanced melanoma. Her work includes an evaluation of Cisplatin and DTIC in patients with inoperable Stage III and IV melanoma, published in 1993. Townsend's recent activity in research is noted as 'No'.

Metrics

  • h-index: 3
  • Publications: 3
  • Citations: 115

Selected Publications

  • Evaluation of Cisplatin and DTIC in Inoperable Stage III and IV Melanoma (1993)
    American Journal of Clinical Oncology 27 citations DOI OpenAlex

View all publications on OpenAlex →

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics